Search
Now showing items 1-6 of 6
Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
(1987)
The first human vaccines against the malaria parasite have been designed to elicit antibodies to the circumsporozoite protein of Plasmodium falciparum. However, it is not known whether any level of naturally acquired ...
Immunity after treatment of human schistosomiasis mansoni. III. Long-term effects of treatment and retreatment
(Univesity of Nairobi, 1987)
Group mean Schistosoma mansoni reinfection patterns are presented for 2 years after treatment with oxamniquine in 1981 of over 100 9- to 16-year-old Kenyan schoolchildren, and for one year after retreatment in 1983 with ...
Evidence for predisposition of individual patients to reinfection with Schistosoma mansoni after treatment.
(1987)
Statistical analysis of the relationship between intensities of infection before treatment and during reinfection after treatment in a sample of 119 Kenyan schoolchildren demonstrated a positive association, indicating ...
Immunity in human schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children
(Univesity of Nairobi, 1987)
A total of 129 children were treated for Schistosoma mansoni infections, and followed for intensity of reinfection at 3-monthly intervals over a 21-month period. Blood samples were taken before treatment and at 5 weeks and ...
African Burkitt's lymphoma and an Epstein-Barr virus-enhancing plant Euphorbia triucalli
(Univesity of Nairobi, 1987)
Field evaluation of an enzyme-linked immunosorbent assay (ELISA) for Plasmodium falciparum sporozoite detection in anopheline mosquitoes from Kenya
(1987)
An enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody that recognizes a repetitive epitope on the circumsporozoite protein of Plasmodium falciparum was used in Kenya to assess malaria infections in ...